105-19: Ethical Considerations in Psychopharmacology
Discuss ethical considerations in psychopharmacological clinical practice with three nursing experts. Use an ethical decision-making framework to help navigate ethical dilemmas encountered by psychiatric-mental health nurses in clinical practice.
Presenters: Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN
Disclosures: The speaker has indicated a significant financial interest or affiliation with Pfizer, and Johnson & Johnson. Off-label use of medications will not be discussed during this presentation.The activity planners have no conflict of interest to disclose.
Session Length: 1 hour 26 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
- Apply analytic techniques to different types of ethical dilemmas.
- Describe the basics of ethical prescribing including responsible practice, values identification, relational considerations with patients and industry, and issues of professional identity.
Keywords: Ethics, Decision Making
Continuing Nursing Education:
1.5 pharmacology contact hours. * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
17th Annual Clinical Psychopharmacology Institute
Friday, June 7, 2019
3:30pm - 5:00pm
The contact hours for this session expire: June 30, 2021